SPDR S&P Biotech ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

Latest Posts

About This Stock More About This Stock
This Biotech Looks Good With Increased M&A Activity
Article By: InvestorsAlley
Friday, May 20, 2022 3:49 AM EDT
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for acquisitions.
In this article: ACAD, EXEL, XBI
Healthcare Stocks Lead The Way Up As The Market Fades
Article By: Rod Raynovich
Monday, April 11, 2022 3:30 PM EDT
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions.
In this article: IWM, XBI, XLV Also: UNH, IHF, ABBV, BMY, MRK, PFE, RHHBY, REGN
Good Entry Point For Biotech Stocks
Article By: Rod Raynovich
Monday, April 4, 2022 12:12 PM EDT
Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.
In this article: IWM, XBI Also: BMY, MRK, SGEN, TDOC, NTLA, REGN, ABBV
AskSlim Market Week - Friday, March 18
Video By: Steve Miller
Friday, March 18, 2022 2:00 PM EDT
Technical and cycle analysis, and market commentary.
In this video: AAPL, FEZ, IWM, OIL, SPY, XBI, NDX, SPX
Tough Slogging Ahead For Investors, Diversification Is Important
Article By: Rod Raynovich
Monday, March 7, 2022 2:13 PM EDT
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.
In this article: XBI, XLE, XLV Also: LGND, SGEN, SRPT, EVH, CRSP, MDGL

Latest Tweets for $XBI

No tweets yet!



Biotech Review - Waiting For A Reset
Dick Kaplan 2/23/2021 5:25:18 PM

Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.

Leadership (Bio-Tech) Breakout; Good Sign For Broad Market
Abe Jouejati 3/1/2017 4:46:32 PM

My Simple Forecast:

Looks like $XBI has had a positive growth trend. With middle of the year approaching I believe that the cycle will repeat, thus hitting high points again. The seasonal patterns may be based on the rate of discovery of new technology, so cycles may be of unusual lengths. Nonetheless, looks like $XBI is positively correlated to SP500, and it is leading variable. We can anticipate new highs by beginning Q3.

1 to 2 of 2 comments